• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孟鲁司特可修饰辛伐他汀引起的肌病和肝毒性。

Montelukast modifies simvastatin-induced myopathy and hepatotoxicity.

机构信息

Department of Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt.

Department of Pathology, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt.

出版信息

Drug Dev Res. 2019 Nov;80(7):1000-1009. doi: 10.1002/ddr.21581. Epub 2019 Aug 6.

DOI:10.1002/ddr.21581
PMID:31389048
Abstract

Montelukast (MNK) has prominent anti-inflammatory and antioxidant activities. It can protect the liver in different hepatotoxic models in animals. Simvastatin (SMV) is one of commonly used lipid lowering drugs for treatment of dyslipidemia in order to reduce cardiovascular disease. It has severe side effects such as myopathy and hepatotoxicity. The aim of the present study is to investigate the possible effect of MNK on SMV-induced myopathy and hepatotoxicity. Four groups of male rats: control group which received saline via stomach tube, MNK treated group (received 10 mg/kg/day MNK via stomach tube), SMV treated group (received 30 mg/kg/day SMV via stomach tube), and MNK + SMV (combination) group which received both MNK and SMV. All animals were treated for 14 days before obtaining blood and tissue samples. SMV has both hepatotoxic effects and myopathy. SMV caused a significant increase in myoglobin, creatinine kinase, ALT, AST, ALP, and bilirubin but, it decreased total proteins, globulin and albumin levels. Co-treatment of SMV and MNK increased the antioxidant activity significantly. MNK modifies partially the myopathic changes and hepatotoxic effect of SMV. Co-administration of MNK and SMV decreased their toxic potentials on the liver, skeletal muscles, and kidney. They have antioxidant activities when given together that produce muscle and hepatic protective effects.

摘要

孟鲁司特(MNK)具有显著的抗炎和抗氧化活性。它可以在不同的动物肝毒性模型中保护肝脏。辛伐他汀(SMV)是一种常用的降脂药物,用于治疗血脂异常,以降低心血管疾病的风险。它有严重的副作用,如肌病和肝毒性。本研究旨在探讨 MNK 对 SMV 诱导的肌病和肝毒性的可能影响。四组雄性大鼠:对照组经胃管给予生理盐水,MNK 治疗组(经胃管给予 10mg/kg/天 MNK),SMV 治疗组(经胃管给予 30mg/kg/天 SMV),MNK+SMV(联合)组给予 MNK 和 SMV。所有动物在获得血液和组织样本前均接受治疗 14 天。SMV 既有肝毒性又有肌病。SMV 导致肌红蛋白、肌酸激酶、ALT、AST、ALP 和胆红素显著增加,但总蛋白、球蛋白和白蛋白水平降低。SMV 和 MNK 的联合治疗显著增加了抗氧化活性。MNK 部分改变了 SMV 的肌病变化和肝毒性作用。MNK 和 SMV 的联合给药降低了它们对肝脏、骨骼肌和肾脏的毒性潜力。它们具有抗氧化活性,同时具有肌肉和肝脏保护作用。

相似文献

1
Montelukast modifies simvastatin-induced myopathy and hepatotoxicity.孟鲁司特可修饰辛伐他汀引起的肌病和肝毒性。
Drug Dev Res. 2019 Nov;80(7):1000-1009. doi: 10.1002/ddr.21581. Epub 2019 Aug 6.
2
Is montelukast as effective as N-acetylcysteine in hepatic injury due to acetaminophen intoxication in rats?孟鲁司特在大鼠对乙酰氨基酚中毒所致肝损伤中的疗效与N-乙酰半胱氨酸一样吗?
Exp Toxicol Pathol. 2016 Jan;68(1):55-9. doi: 10.1016/j.etp.2015.09.008. Epub 2015 Oct 14.
3
Simvastatin attenuates cisplatin-induced kidney and liver damage in rats.辛伐他汀减轻顺铂诱导的大鼠肾和肝损伤。
Toxicology. 2007 Feb 12;230(2-3):256-64. doi: 10.1016/j.tox.2006.11.073. Epub 2006 Dec 8.
4
Innovative HPTLC method with fluorescence detection for assessment of febuxostat-montelukast combination and study of their protective effects against gouty arthritis.创新性 HPTLC 方法结合荧光检测用于评估非布司他-孟鲁司特联合用药及其对痛风性关节炎的保护作用研究。
Analyst. 2018 Sep 10;143(18):4366-4378. doi: 10.1039/c8an00772a.
5
The protective effect of montelukast sodium on carbon tetrachloride induced hepatopathy in rat.孟鲁司特钠对四氯化碳诱导的大鼠肝病的保护作用。
Prostaglandins Other Lipid Mediat. 2009 Apr;88(3-4):82-8. doi: 10.1016/j.prostaglandins.2008.10.004. Epub 2008 Nov 11.
6
The influence of simvastatin at high dose and diltiazem on myocardium in rabbits, the biochemical study.
Acta Pol Pharm. 2006 Sep-Oct;63(5):386-90.
7
Protective potential of montelukast against hepatic ischemia/reperfusion injury in rats.孟鲁司特对大鼠肝缺血/再灌注损伤的保护作用。
J Surg Res. 2010 Mar;159(1):588-94. doi: 10.1016/j.jss.2008.08.006. Epub 2008 Sep 7.
8
Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.选择性半胱氨酰白三烯1(CysLT1)受体拮抗剂孟鲁司特可减轻大鼠慢性肾衰竭诱导的多器官损伤。
Prostaglandins Other Lipid Mediat. 2007 Jun;83(4):257-67. doi: 10.1016/j.prostaglandins.2007.01.013. Epub 2007 Jan 20.
9
Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family.肌酸激酶水平正常的他汀类药物相关性肌病。来自一个挪威家庭的病例报告。
APMIS. 2005 Sep;113(9):635-7. doi: 10.1111/j.1600-0463.2005.apm_270.x.
10
Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats.孟鲁司特和厄贝沙坦可改善果糖诱导的大鼠代谢综合征中的代谢和肝脏紊乱。
Eur J Pharmacol. 2014 Feb 5;724:204-10. doi: 10.1016/j.ejphar.2013.12.024. Epub 2013 Dec 24.

引用本文的文献

1
Formation of PEG-PLGA Microspheres for Controlled Release of Simvastatin and Carvacrol: Enhanced Lipid-Lowering Efficacy and Improved Patient Compliance in Hyperlipidemia Therapy.用于辛伐他汀和香芹酚控释的聚乙二醇-聚乳酸-羟基乙酸共聚物微球的制备:在高脂血症治疗中增强降脂疗效并改善患者依从性
Polymers (Basel). 2025 Feb 21;17(5):574. doi: 10.3390/polym17050574.
2
Investigation of Montelukast Effect on Rosuvastatin Induced Late Puberty in Rats.孟鲁司特对大鼠瑞舒伐他汀诱导的青春期延迟影响的研究。
J Hum Reprod Sci. 2022 Jul-Sep;15(3):228-232. doi: 10.4103/jhrs.jhrs_56_22. Epub 2022 Sep 30.
3
Long-Term Administration of Abacavir and Etravirine Impairs Semen Quality and Alters Redox System and Bone Metabolism in Growing Male Wistar Rats.
长期给予阿巴卡韦和依曲韦林会损害生长雄性 Wistar 大鼠的精液质量,并改变其氧化还原系统和骨代谢。
Oxid Med Cell Longev. 2021 Jul 29;2021:5596090. doi: 10.1155/2021/5596090. eCollection 2021.
4
Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence.孟鲁司特药物可能改善新冠预后:证据综述
Front Pharmacol. 2020 Sep 4;11:1344. doi: 10.3389/fphar.2020.01344. eCollection 2020.